Sage Therapeutics Inc (NASDAQ:SAGE) currently has a daily average trading volume of 1.58M but it saw 1545675 shares traded in last market. With a market cap of 576.75M USD, the company’s current market price of $9.21 came rising about 0.11 while comparing to the previous closing price of $9.2. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.47 and as low as $4.62. In the recent trading on the day, stock has struck highest price mark of $9.155 while lowest mark touched by it was $9.25.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BofA Securities which resumed the stock as “Underperform” in its note to investors issued on March 11, 2025, recommending a price target of $5 for it. RBC Capital Mkts upgraded its recommendation for the stock as a “Sector Perform” from “Underperform” on November 21, 2024 while assigning a price target of $4.
Over the week, SAGE’s stock price is moving 1.43% up while it is 35.24% when we observe its performance for the past one month. Year-to-date it is -15.81% down and over the past year, the stock is showing an upside performance of 69.61%.
Currently, Sage Therapeutics Inc’s total number of outstanding shares is 62.54M. Company’s return on investment (ROI) stands at -84.40% and return on equity (ROE) at -63.53%. Stock’s beta reads 0.26. Stock has a price to book (P/B) ratio of 1.41 while price to sale or P/S ratio amounts to 12.17. Its return on asset (ROA) is -57.29% on average.
